Brian Kobilka's lab at Stanford University and the SFMB laboratory at the Université Libre de Bruxelles

Chia-Yi Lin and Alexander Ball, both scientists-turned-industry professionals at GeneTex, trace how the Years later, GeneTex now has both polyclonal and recombinant monoclonal options for LGR5 - but the process GeneTex had nothing for that target at the time. What Scientists Who Cross Into Industry Learn That Those at the Bench Cannot Both Ball and Lin arrived at GeneTex from active research positions, and both describe a shift in how they understood antibodies

Brian Blagg at Notre Dame on β-and-GRP94-selective compounds has produced proof-of-concept IV data that Brian Blagg's KU-32 actually promotes neuronal survival in diabetic peripheral neuropathy and is now

Her current research integrates both frameworks - examining how the GLP-1 receptor engages its transducer A decade later, she is deliberately bringing both ends of that arc together. passages in the conversation concerns the habit of nodding along when a supervisor is speaking and nothing make asking safe, and by the unavoidable evidence that unacknowledged confusion produces problems on both

Biased signaling is real but harder to exploit than expected GPR68 couples to both Gq and Gs, and the The group needed someone to visit Gilman's lab to learn radioligand binding — and he was the one with nothing And the answer was nothing." "We don't know what we don't know.

Brian Kobilka , 2012 Nobel Laureate in Chemistry.

Some journals are beginning to accept negative data, and both agree this matters structurally. timelines 40:54 - Upcoming GPCR conferences in Leipzig and Dusseldorf Selected Quotes "It's like there's nothing

first described and when working on them was a high-risk research bet, the CGRP drug approvals are both drugs targeting that pathway can abolish chronic migraine entirely for some patients - while doing nothing

pride as much as a signal that the field recognized what real-time, live-cell measurement offers that nothing I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the

In the early 2000s there were screening campaigns against these receptors, but nothing promising emerged If the receptor system and the tool are both unknowns, it becomes very difficult to interpret the results The worst thing you can do in science is nothing.

prone to activation, and resistant to pharmacological blockade - and why those properties have shaped both Bitterness and toxicity are not the same thing - and the field had to prove it A long-standing assumption in both rapid-assembly international collaboration that surveyed tens of thousands of patients and found that while both developing a recommendation system - trained on known receptor-ligand pairs and the structural properties of both Her work focuses on both sweet and bitter taste receptor GPCRs and her lab established the BitterDB .

Nothing held back. Nothing is restricted. What happens to my $49 if I become a member? It becomes a credit. Nothing is held back. You get everything Premium members have for 14 days. Can I start anytime?

Both Chuck and Joe agree: accounting is like solving puzzles. Germain Networking: Relationship Over Transaction Both guests stress that business is built on relationships episode, Yamina and her guests underscore that finance and science share more than most people think —both

therapeutic targets beyond sensory biology The moment when open-access GPCR data integration improves both pharmacology, contributing as a professor, senior lecturer, editorial board member, and scientific officer in both

big pharma and biotech, encompassing functional assay development, GPCR internalization research, and both Awarded patents and a proven record in both target and pathway identification, his drive centers on integrating

assay systems, and why fluorescence-based assays paired with careful synthetic planning open doors for both –2016) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both

They both discussed the intense competition in their home province, Quebec, and its impact on students Additionally, they both agreed on the importance of mentorship in building confidence, with Yamina sharing They both agreed on the value of these strategies.

Discovery What Partners Say Here’s what it’s like to work together — from people I’ve supported on both Her involvement consistently elevates both the scientific discipline and the quality of portfolio-level , define clear go/no-go criteria, and integrate ADME and mechanistic assays in a way that reflected both

In knockout mice, loss of CXCR3 abolishes response to both anti-PD-1 and anti-CTLA-4, reframing the receptor Both required trusting the data when the conceptual framework was telling the team they must be wrong Both landed in Nature and Cell respectively. 7. Team science is structural, not decorative.

She describes the shift as both technically disorienting and visually striking - a different relationship from an academic-industry collaboration that would not have produced the allosteric modulators without both academia stopped making sense 30:54 From Field Application Scientist to Product Manager 38:58 What both

He has successfully built numerous global life science, leadership teams, & works closely with both clients

GPCR ecosystem, contributing both expertise and tools that align directly with the needs of scientists central role in the development and validation of Celtarys’ proprietary synthetic technology and is both

Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both After a well needed break from the grind, I am now a scientific/business consultant for clients both

such as the activation of cell surface receptors by intracellular proteins; the regulation of GPCRs by both

communication, and peer learning — especially from undergraduate trainees — shape his development as both In addition, he plans to continue studying how neuromodulators, both exogenous and endogenous, can influence

went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs at both

Gabriele Kockelkoren About Gabriele Kockelkoren I have a strong background in both physics and molecular

Thomas Südhof's lab — that a cell adhesion molecule and a GPCR, studied separately for over a decade, both On a colleague's suggestion, he recognized that both proteins had independently been shown to bind alpha-latrotoxin Südhof himself was skeptical; the field had studied both proteins for over a decade without making the

Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for

Smith’s team has made advances in the understanding of how an orphan GPCR exerts its effects both in